EGFR and ovarian serous carcinoma: In serous ovarian carcinoma, Lassus et al. reported no EGFR mutations in exons 18, 19, or 21 in a study of 198 samples, despite finding 17% EGFR overexpression and 12% EGFR amplification (>five copies per cell), both associated with poor outcomes [45].